Guangzhou Bio-gene Technology Co., Ltd
Clinical trials sponsored by Guangzhou Bio-gene Technology Co., Ltd, explained in plain language.
-
Radical immune cell therapy tested for Hard-to-Treat autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy for people with severe autoimmune diseases like lupus and rheumatoid arthritis. Doctors will modify a patient's own immune cells (called CAR-T cells) to target and potentially reset the faulty immune system. The main go…
Phase: NA • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New 'Living Drug' trial targets Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing a new type of personalized cell therapy called B7H3 CAR-T in people with advanced solid tumors. Doctors will take a patient's own immune cells, modify them in a lab to better target their cancer, and then infuse them back. The main goals are to c…
Phase: NA • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New immune cell therapy tested for Tough-to-Treat colon cancer
Disease control Recruiting nowThis early-stage study is testing the safety and initial effectiveness of a new type of personalized immune cell therapy called CDH17/GUCY2C CAR-T in patients with advanced colorectal cancer. The therapy involves modifying a patient's own immune cells to target and fight their ca…
Phase: NA • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC